Organogenesis Holdings (ORGO) Shares Outstanding (Diluted Average) (2018 - 2026)

Organogenesis Holdings' Shares Outstanding (Diluted Average) history runs 9 years deep, the most recent figure standing at $127.8 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 1.19% year-over-year to $127.8 million; the TTM figure through Mar 2026 stood at $127.8 million (up 1.19% YoY), while the FY2025 annual figure was $130.2 million, down 1.08% from the prior year.
• Shares Outstanding (Diluted Average) was $127.8 million for Q1 2026 at Organogenesis Holdings, down from $130.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $133.9 million in Q3 2024 to a low of $126.3 million in Q1 2025.
• Historically, Shares Outstanding (Diluted Average) has averaged $131.2 million across 5 years, with a median of $132.4 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Diluted Average) rose 1.78% in 2023, then fell 5.41% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $132.4 million in 2022, then grew by 0.27% to $132.7 million in 2023, then retreated by 0.81% to $131.7 million in 2024, then dropped by 1.08% to $130.2 million in 2025, then decreased by 1.88% to $127.8 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $127.8 million (Q1 2026), $130.2 million (Q4 2025), and $126.7 million (Q3 2025), per Business Quant data.